1 INTRODUCTION. 1.1 Historical background
|
|
- Hilary Horton
- 5 years ago
- Views:
Transcription
1
2 1 Parasites are living organisms that use other living creatures like our body for food and a place to live. We can get them from contaminated food or water, a bug bite, or sexual contact. Parasitic diseases can cause mild discomfort or be deadly. Parasites range in size from tiny, one-celled organisms called protozoa to worms tl13t can be seen with the naked eye. Parasitic diseases were always a heavy burden for humanity. Protozoan parasites are responsible for several important diseases that threaten the lives of nearly one quarter of the human population world-wide. Leishmaniasis is one of the six major parasitic diseases identified by WHO for extensive research for its control and eradication ( With more than 70,000 deaths per year from visceral leishmaniasis, it is second only to malaria for de[!ths associated with parasitic infection. Leishmaniasis is widely recognized as one of the major neglected diseases associated with poverty (Alvar et ai., 2006). The disease is spreading in several areas, as a consequence of massive rural urban migration and its association with AIDS. Leishmania I HIV association is indeed considered by the WHO as a real threat especially in Spain and Mediterranean countries in south Western Europe ( 2000). 1.1 Historical background The disease has a long history; description of conspicuous lesions has been discovered on tablets from King Ashurbanipal from the 7th century BC, some of which may have been derived from even earlier texts from 1500 to 2500 BC. Arab physicians including Avicenna in the 10th century gave detailed description of what was called Balkh sore (Cox, 2002). As for the new world, evidence of cutaneous form of the disease was found in Ecuador and Peru in pre-inca potteries depicting skin lesions and deformed faces dating back to the first century CE ( Leishman identified certain organisms in smears taken from the spleen of a patient who had died from "dum-dum fever" (Dhum dhum is an area c:ose to Calcutta) and in 1903 Captain Charles Donovan ( ) described theni as being new organism
3 ( Eventually Ronald Ross established the link with the disease and named the organism Leishmania donovani. 1.2 The Leishmania Parasite: Classification Evolutionarily Leishmania are closely related to the trypanosomes and have probably evolved from the lower insect trypanosomatids (McGhee & Cosgrove, 1980). The genus Leishmania can be classified as: Phylum Sarcomastigophora Sub. Phylum Mastigophora Class Zoomastigophora Order Kinetoplastida Sub-order Trypanosomatina Family T rypanosomatidae 1.3 Geographical Distribution The geographical distribution of leishmaniasis is restricted to tropical and temperate regions, the living area of the sandfly. The leishmaniasis is considered to be endemic in 88 countries (16 developed countries and 72 developing countries) on four continents (Figure. I. 1 ). Ninety per cent of visceral leishmaniasis cases are found in Bangladesh, Brazil, India, Nepal and Sudan. The disease is completely absent from western hemisphere except the eastern parts of Brazil. Figure 1.1 World wide geographical distributions of Visceral and Cutaneous I Mucocutaneous leishmaniasis ( 2
4 To date, the greatest prevalence of LeishmaniafHIV co-infection has been in the Mediterranean basin. Of more than 2,000 cases notified to the WHO, 90 per cent of them come from Spain, Italy, France and Portugal (Figure 1.2). Figure 1.2 Countries with endemic leishmaniasis and with Leishmania-HlY co-infection. global distribution of leishmaniasis; countries that have reported co-infection (Desjeux & Alvar, 2003). 1.4 Leishmaniasis in India In the Indian sub-continent, the most common endemic form of the dieses is visceral leishmaniasis (VL or Kala-azar) and this is mainly found in the eastern parts of the country viz. Bihar, West Bengal, eastern districts of Uttar Pradesh, Assam, foothills of Sikkim and to a lesser extent in Tamil Nadu and Orissa (Marin kelle, 1980). MAP OF utar SHOWIIO ENoa.cm OF KAlA-AZAIt H.rttW;-.; 0 _~ D LOW BIIIEIE NEPAL Uttar Pradesh West Bengal Figure 1.3 Map of Bihar State, India, showing distribution of resistance to pentavalent antimonials in kala-azar-endemic areas (Simon et ai., 2006). 3
5 -~ The Bihar state has witnessed two major epidemic outbreak of Kala-azar in the year IlJ78 and Presently 12 districts, out of total 38 in Bihar are badly affected with it (Figure 1.3). In 2005 the health ministers of three Member States of WHO's South-East Asia Region, India, Nepal and Bangladesh, had signed a Memorandum of Understanding pledging to collaborate to eliminate VL from their countries. 1.5 Clinical manifestations and Pathology of the disease The clinical spectrum of Leishmaniasis encompasses subclinical (inapparent), localised (skin lesions), and disseminated infection (cutaneous, mucosal, or visceral) (Table 1.1) (Chang and Fong, 1983). Table 1.1 Summary of clinical manifestations and geographical distribution of Leishmania I Species Clinical Manifestation Ceographical Distribution, L. ama::onensis Visceral,cutaneous,mucocutaneous, New World: South and Central America L. bra::iliensis Cutaneous. mucocutaneous New World: Throughout South America L. chagasi Visceral New World: South and Central America L. donovani Visceral (kala-azar) Old World: China, India, Bangladesh L. inian/llm Visceral. cutaneous Old World: North Central Asia, Northwc~t I China, Uzbekistan, Middle East IL. major Cutaneous Old World: Africa, Middle East,Nol1hern A~ia IL. mexicana Cutaneous, mucocutaneous New World: Southern Mexico, Belize, nol1hern Guatemala, southern Texas I Cutaneous Leishmaniasis (CL): Cutaneous leishmaniasis (CL) is the 1110st common form and also known as oriental sore, an infection characterized by ulcerative skin lesion in the face, on arms or legs (Figure l.4a). CL is principally caused by L. major, L. lropica and L. l71exicana. Although the lesions ',viii persist and disseminate. cutaneous leishmaniasis is generally a self-healing disease. However, it's most severe form, recidivisms Leishmaniasis, is very difficult to treat, long lasting, destructive and disfiguring Diffuse cutaneous Leishmaniasis (DCL): Diffuse cutaneous leishmaniasis (DCL) is a mutilating disease caused by L. mexicana. The infection disseminates with chronic skin lesions resembling those of leprotamous leprosy, :ll1d is difficult to treat. 4
6 Figure 1.4 (a) Cutaneous Leishmaniasis (CL) (www3.baylor.edu); (b) Mucocutaneous leishmaniasis (MCL) or espundia. Active lesions in nasal mucosal tissue with septal perforation and disfigurement of the nose and swelling of upper lip. (Calvopina et ai, 2006) Mucocutaneous Leishmaniasis (MeL): Also called 'espundia' In South America. It is mostly related to Leishmania species of the New World such as L. braziliensis, L. panamensis and L. guyanensis, but mucosal lesions have been reported in the Old World due to L. donovani, L. major and L. in/anlum in immunosupresed patients (Desjeux, 1996). The parasite invades the mucocutaneous region of the body and spread to the oronasal/pharyngeal mucosa. The soft tissues and cartilage of the oronasal/pharyngeal cavity undergo progressive erosion (Figure l.4b). In contrast to cutaneous Leishmaniasis, these lesions do not heal spontaneously. Suffering and mutilation are severe and death occurs as a result of bronchopneumonia or malnutrition Visceral Leishmaniasis (VL) : It is also known as 'kala-azar'. It is caused by L. donovani. Initially, the disease is characterized by high fever, headache, chill, malaise, dizziness, anorexia, and vomiting and weight loss (Desjeux, 1996; WHO, 1996 & 1998). In chronic stage the disease IS followed by hepatomegaly, splenomegaly, Iymphoadenopathy, occasional acute abdominal pain, emaciation, anemia, leucopenia, and blackness of skin (Figure 1.5a&b) hence the name given Kala-azar or Black fever. It is the most severe form of Leishmaniasis and is usually fatal if left untreated. The incubation period can be months or years and, unlike the cutaneous forms of Leishmaniasis, it involves the internal organs. 5
7 Figure 1.5 (a) A young Sudanese boy with visceral leishmaniasis (b) splenomegaly (enlargement of spleen) and hepatomegaly (enlargement of liver) in visceral leishmaniasis (A CRUMP, TOR, HO/SCIENCE PHOTO LIBRARY) Post kala-azar dermal Leishmaniasis (PKDL): Post kala-azar dermal Leishmaniasis is a sequel to the infection with L. donovani. It is a type of non-ulcerative cutaneous lesion, developed in about 10% of kala azar patients generally one or two years after completion of antimonial treatment (Zij Istra et ai., 1991). 1.6 Leishmania life cycle and morphology Leishmania parasite leads digenetic life cycle between invertebrate sand fly and vertebrate host and differentiate into two morphologically distinct stages, insect-stage flagellated promastigotes and mammalian-stage intracellular amastigotes Promastigote or Leptomonad stage: They are long, slender cells and measure approximately ~m by \ ~m with a ] 5-28 ~ anterior flagellum which functions in locomotion and attachment to the insect gut wall (Figure 1.6a) (Herwaldt, 1999; Bogitsh & Cheng, 1990). The surface membrane has binding sites molecules such as glycoproteins and mannose receptors that are important for uptake of promastigotes by macrophages Amastigotes or Leishman stage: Amastigotes are smaller than promastigotes and appear non-flagellated. They are ovoid in shape and measure approximately 2-4 J..lm in diameter. This stage is found in parasitophorus vacuole of macrophages. The outer membrane has polysaccharide component but there is no surface coat (Figure 1.6b) (Herwaldt, 1999). 6
8 Figure 1.6 (a) Morphological features of L. donovani promastigotes and (b) axenically-cultured amastigotes (Habtemariam, 2003) Establishment of infection: Sandflies of the genera Phlebotomus in the case of Old World Leishmaniaspecies, or Lutzomyia for New World Leishmania species are infected with the Leishmania parasite mainly from natural reservoir hosts such as canines and rodents (Figure 1.7). Sandfly Stag-. HumanStagn Figure 1.7 Life Cycle and Morphological Stages of Leishmania 7
9 After ingestion by the fly, procyclic promastigotes reproduce in the lumen of the digestive tract by longitudinal binary fission. Approximately four days after ingestion, the promastigotes undergo a developmental transition into metacyclic promastigotes through a process called metacyclogenesis. Metacyclic promastigotes are longer and narrower, have a longer flagellum, and display changes in surface coat proteins which together result in a form of the parasite that is adapted to infect macrophage cells (Spath & Beverley, 2001). Metacyclic promastigotes migrate anteriorly to the esophagus and pharynx of the fly, and when the sandfly next feeds, some are dislodged and deposited on the skin of the host through the sandfly's proboscis. The cells are then phagocytosed by macrophages. The parasite begins a transformation inside the endocytotic parasitophorous vacuole and change into amastigote form. These cells divide by binary fission and accumulate in the macrophage until it ruptures and releases its amastigotes which are then free to infect other macrophages. This cycle continues and results in one of the clinical symptoms of leishmaniasis with different speci.:::s having different tropisms for macrophages in particular organs in the host (Bogitsh & Cheng, 1990). 1.7 Diagnosis of the disease The clinical and epidemiological findings in various forms of leishmaniases are non pathognomonic and these can mimick several other conditions. Hence a laboratory diagnosis is required to confirm the clinical suspicion. The diagnostic tools used for each leishmanial syndrome viz. visceral, cutaneous, and mucocutaneous form vary but the gold standard in each case remains to be the demonstration and isolation of the parasite from appropriate tissues. VL is usually diagnosed by demonstrating the parasite in aspirates from the spleen, bone marrow or lymph nodes, but this method is unsuitable in field settings. Quick differential diagnosis of leishmaniasis (Sundar and Rai, 2002) can be achieved with the direct agglutination test (DA T), which is quantitative, and uses a freeze-dried antigen (Oskam et at., 1998), the urine antigen-detection test (dipstick K39) that is particularly useful in immunocompromised patients and to evaluate treatment efficacy (Attar et ai., 2001; Sundar and Rai, 2002). For CL, parasitological diagnosis is based on skin smears. For MCL cases, diagnosis relies on serological tests. This is however, not helpful in most cases because the antibody levels are too low, whereas manifestations of cell-mediated immunity e.g. Skin-test reactivity, usually develop during an active infection (Herwaldt, 1999). 8
10 Table 1.2 Epidemiological traits of leishmaniasis: distribution, reservoirs and clinical syndromes Species Geographic distribution Reservoir Clinical syndrome L. donovani Africa, India, Bangladesh, East Asia, Humans, rodents VL,PKDL (Old world) China L. infantum S. Europe, Mediterranean, Eastern China, Dogs, foxes, ackals VL,CL (Old world) Central Asia L. major Middle East, Indian, Northwestern China, Humans, rodents CL (Old world) Africa L. tropica Middle East, Indian, Western Asia Humans, rodents CL (Old world) L. aethiopica East Africa Hyraxes DCL,MCL (Old world) L. chagasi Central and South America, Dogs, foxes VL,CL,PKDL (New world) L. amazonensis South America Forest rodents CL, VL,PKDL (New world) MCL,DCL L. braziliensis Central and South America Forest rodents CL,MCL (New world) L. mexicana Central America Forest rodents CL, DCL (New world) 1.8 Prevention Leishmaniasis Control measures target the interruption of the transmission cycle. Depending on the circumstances (eg. zoonotic or anthroponotic transmission), the control of either the reservoir or the vector is advisable. The human link in the transmission cycle can be controlled by taking personal precautions Vector control: One important goal is the destruction of breeding places of sandtly. This involves the closure of cracks in walls and the removal of rubble. A common measure is the spraying of houses with insecticides (Alexander et ai., 1995; Tayeh et al., 1997). Biological control measures seem to be effective as well (Robert et ai., 1997). In India, kala-azar had been almost eradicated after an anti-malaria campaign. Since the spraying of houses has been stopped, the disease has returned Control of the reservoir: One effective measure for the control of zoonotic. In the northern Jordan Valley CL cases became rare in recent years due to extensive agriculture and development which had resulted in the destruction of the natural habitat of the Psammomys. In order to control VL, different measures have been employed. It has been shown in a study in Brazil that the removal of infected dogs led to a lower incidence but did not eradicate the disease (Ashford et ai., 1998). Vaccination of dogs might be an alternative approach for the future (Tesh, 1995). 9
11 1.8.3 Vaccine against Leishmaniasis : There is no vaccine against Leishmania in routine use anywhere in the world, however many vaccine candidates are currently being tested. These include the use of killed or attenuated parasites, protein or synthetic peptides, and even naked DNA plasm ids - all of which have shown the limited protection from infection in animal models (Handman et ai., 2001). Some of the genes or gene products that have conferred protection in vaccine testing display developmental gene regulation (Almeida et ai., 2002; Saravia, 2005; Walker, 1998). Several vaccine preparations are in more or less advance stage of testing which are summarized in the table 1.3. Table 1.3 Summary of vaccination studies in humans and experimental models I Antigen I Mode ~~~~;~~ization I Protection IIHost I~==============~~============~ Live promastigotes I Prophylactic (Russia, Dependent on virulence IHumans 1~ ==================~ ~Is=ra=e=I)============~:~==============~~. I ========~ Killed promastigotes I Prophylactic Ivariable IIHumans 1~ ==================~ ~(M==id=d=le=E=a=s=t,=B=r=az=i=I)====~~. I ==============~.~. ========~I IKilled promastigotes with BCG IITherapeutic (Brazil) IIHigh cure rate IIHumans I~==============~~============~ ~======~I Killed promastigotes with BCG IProPhYlactic (Iran) I N? prot~ction, transient IHumans.. stimulation. ~==============~:~============~ ~======~I Killed promastigotes with IL-12lproPhYlactic IIGOOd 11~~i;ates, mice, I~================~~==============~ IIrradiated promastigotes IIProphylactic IIGood IIMice I I~==============~~============~ ILive attenuated promastigotes IIProphylactic IIGood IIMice I ~============~~============~~======~I Recombinant or native gp63 and IProPhYlactic IIGOOd I Mice, primates synthetic peptides.... Recombinant or native ~============~~============~~======~I IProPhYlactic I Excellent but.dependent Dice gp46/m2/psa-2 on conformation and adjuvant ~============~~======~==~ IRecombinant LACK IIProphylactic IIGood, enhanced by IL-1211Mice i====~ IA2, P4, and P8 IIProphylactic IIGood IIMice 1~IF=la=g=el=la=r=a=nt=ig=e=n=L=C=R=l======I:I~p=ro=P=h=y=la=ct=ic========~IIGood II~~~~ DNA gp63, PSA-2, and Prophylactic or therapeutic IGOOd IIMice 1~IM=ic=e======~ 1.9 Treatment of Leishmaniasis The only effective way to control Leishmania infections currently is chemotherapy. The treatment of choice for all types of leishmaniasis is based on pentavalent antimonials despite of its cardiac and renal toxicity and difficulty of administration (Bryceson et ai, 10
12 1985; WHO, 1990). Pentavalent antimonials are being used for treatment for more than 50 years. Currently recommended dose of Sb V is 20 mg/kg/day (MKD) for 30 days (Herwaldt and Berman, 1992). The mode of action of SAG is shown to be the inhibition of glycolytic pathway and fatty acid oxidation pathway in the parasite (Berman et al., 1987). However, in recent years, a large scale increase in clinical resistance to pentavalent antimonials has been reported (Lira et al., 1999). In India as many as 65% of the previously untreated patients failed to respond promptly or relapse after therapy with antimony drugs due to development of drug resistance (Sundar et a!., 2000). Further, HIV co-infected individuals often relapse after traditional antimonial treatment. Pentamidine (Second line drug) was the drug of choice for some time but high toxicity and resistance to parasite had stopped its use. Amphotericin B is now becoming the treatment of choice for visceral leishmaniasis, especially in cases refractory to Sb v and/or pentamidine but severe side effects and high cost limit their use (Mishra et a!., 1992; Bryceson, 1996; Herwaldt, 1999). Ongoing research on drugs for treating leishmaniasis includes Miltefosine, the first oral agent, currently undergoing trials. Miltefosine, registered for use in India in 2002, is an alkylphosphocholine for treatment of VL. Phase IV clinical trials that are aimed at evaluating the level of compliance were recently concluded. Owing to its teratogenic potential, the drug cannot be administered to females of childbearing age unless contraception is taken. With this exception, trials in India have confirmed the safety and efficacy of the drug (Eibl, 2000). Paramomycin, an aminoglycoside, is also currently undergoing Phase III clinical trials in India, so far it has shown great promise and it has the potential for multidrug therapy (Thakur, 2000). Other types of drugs are also being developed that target the immune system rather than the parasite itself. These 'immune modulators' enhance natural immunity and lead to more rapid cures. One such drug, which targets a primitive recognition system in phagocytic cells (involved in initial immune system response and wound healing) is Imiquimod, a cream used in the treatment of skin cancer. Proven to have benefit in mouse models, this is now being tested in patients and initial studies show some promise, particularly in combination with other drugs. Local injections of interferon-y can increase cellular immunity, but immunotherapy has so far proved unsuccessful (Awasthi et a!., 2004; Bryceson, 1996; Herwaldt, 1999). 11
13 Thus, drugs available for the treatment of Leishmaniasis are either inadequate, or compromised by the development of resistance. This has led to research on the basic studies to evaluate the significant differences between host and parasite which will lead to the development of logical approaches to chemotherapy. Inspite of significant progress in the past few decades, much remains to be discovered on the biochemicalmolecular mechanisms governing important properties of the parasite such as virulence, drug resistance, genetic polymorphism, regulation of gene expression, kinetoplast DNA function etc. Addressing these questions will lead in the identification of new drug targets or vaccine molecules. 12
The Most Common Parasitic Infections In Yemen. Medical Parasitology
The Most Common Parasitic Infections In Yemen Medical Parasitology ﻓﺎﯾز اﻟﺧوﻻﻧﻲ / د 2 : is a vector-borne disease that transmitted by sandflies and caused by obligate intracellular protozoa of the genus
More informationHAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine
HAEMOFLAGELLATES Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine Objective Can describe the morphology, life cycle, pathology, diagnosis and prevention of Leishmania spp. and Trypanosoma
More informationLeishmaniasis, Kala Azar(The Black Fever)
Leishmaniasis, Kala Azar(The Black Fever) By Lawrence Hall Etiologic agent Protist obligate intracellular parasite, Transmission Vectors Phylum: Euglenozoa (genus Leishmania) Over 21 species that infect
More informationWorld Health Organization Department of Communicable Disease Surveillance and Response
WHO Report on Global Surveillance of Epidemic-prone Infectious Diseases World Health Organization Department of Communicable Disease Surveillance and Response This document has been downloaded from the
More informationMorphological forms of hemoflagellates
Parasitology Lecture: 1 Hemoflagellates (blood and tissue flagellates) *Classification: - Sub-kingdom: Protozoa -Phylum: Sarcomastigophora -Sub-phylum: Mastigiphora -Class: Zoomastigophora د. رائد *Flagellates
More informationWhat is Kala-azar? What are Signs & Symptoms of Kala-Azar?
What is Kala-azar? Kala-azar is a slow progressing indigenous disease caused by a protozoan parasite of genus Leishmania In India Leishmania donovani is the only parasite causing this disease The parasite
More informationBIO Parasitology Spring 2009
BIO 475 - Parasitology Spring 2009 Stephen M. Shuster Northern Arizona University http://www4.nau.edu/isopod Lecture 5 Discovery of the Disease In 1924 the Kala-Azar Commission noted that the distribution
More information~Trichinella Spiralis:
Musculoskeletal System **Today we are going to talk about the parasites that affect the musculoskeletal system ~Trichinella Spiralis: It s a small nematode that measures to about 2-3mm in length. In general
More informationCutaneous Leishmaniasis : Global overview
Cutaneous Leishmaniasis : Global overview Meeting of stakeholders for selected Health R&D Demostration Projects, 7-10 May 2014, WHO, Geneva Dr. Daniel Argaw Dagne, NTD/WHO CSR - DDC AFRO Leishmaniasis
More information2.Trichomonas vaginalis
2.Trichomonas vaginalis 1. Pathogenic to human &causes vaginitis (trichomoniasis). 2. troph. Is round or pear like in shape, contains 4-6 flagella, all originating from anterior end & only one extend posteriorly.
More informationLaboratory diagnosis of Blood and tissue flagellates
Laboratory diagnosis of Blood and tissue flagellates (Leishmania and trypanosma) Sarah Alharbi Clinical Laboratory department Collage of Applied Medical Sciences King Saud University Leishmania and trypanosma:
More informationLeishmaniasis. CDR R.L. Gutierrez Oct 2014
Leishmaniasis CDR R.L. Gutierrez Oct 2014 Overview Protozoan parasite(s) of tissue and WBCs Many species / Many Syndromes (Cutaneous / Visceral) Pathogen: Location - Old World vs. New World Host: Immune
More informationFrequently Asked Questions on Visceral Leishmaniasis (Kala-azar)
SEA-CD-274 Frequently Asked Questions on Visceral Leishmaniasis (Kala-azar) World Health Organization 2013 All rights reserved. Requests for publications, or for permission to reproduce or translate WHO
More informationControl of leishmaniasis
SIXTIETH WORLD HEALTH ASSEMBLY A60/10 Provisional agenda item 12.3 22 March 2007 Control of leishmaniasis Report by the Secretariat BACKGROUND 1. Leishmaniasis is endemic in 88 countries in the world and
More informationElimination of VL in the Indian subcontinent is it achievable?
Elimination of VL in the Indian subcontinent is it achievable? P Das Rajendra Memorial Research Institute, Patna Jorge Alvar DNDi, Geneva Bhawna Sharma DNDi, India Leishmaniasis 350 million at risk worldwide
More informationVISERAL LEISHMANIASI S (KALA-AZAR)
VISERAL LEISHMANIASI S (KALA-AZAR) :OUTLINES DEFINITION. EPIDEMIOLOGY. PARASITE & VECTOR. PATHOLOGY CLINICAL & LIFE CYCLE. PICTURE. COMPLICATIONS. DIAGNOSIS. INVESTIGATIONS. MANAGEMENT TREATMENT S CONTROL.
More informationWelcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar
Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar AA 55M presented with sores on left olecranon and umbilical area Umbilical sores present for 3 weeks Left olecranon lesions for 1 week
More informationSodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan
Sodium Stibogluconate treatment for cutaneous leishmaniasis: A clinical study of 43 cases from the north of Jordan Mamoun Mohammad Al-Athamneh Hiathem Qasem Abu Al-haija Ra ed Smadi Ayman S. Qaqaa Heba
More informationBlood Smears Only 6 October Sample Preparation and Quality Control 15B-K
NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 6 October 5 The purpose of the New York State Proficiency Testing Program in the category of Parasitology - Blood Smears Only is
More informationTherapeutic Options for Visceral Leishmaniasis
Drugs (2013) 73:1863 1888 DOI 10.1007/s40265-013-0133-0 REVIEW ARTICLE Therapeutic Options for Visceral Leishmaniasis Begoña Monge-Maillo Rogelio López-Vélez Published online: 30 October 2013 Ó The Author(s)
More informationLeishmaniaand Leishmaniasis
Leishmaniaand Leishmaniasis Methodenseminar SS2014 IRMA SCHABUSSOVA, PhD Institute of Specific Prophylaxis and Tropical Medicine; Medical University Vienna Kinderspitalgasse 15, A-1090 Vienna, Austria
More informationLeishmaniasis. MAJ Kris Paolino September 2014
Leishmaniasis MAJ Kris Paolino September 2014 Thanks to COL (Ret) Kent Kester MAJ Leyi Lin http://www.niaid.nih.gov/topics/leishmaniasis History Sir William Boog Leishman (1865-1926) Matriculated at the
More informationSUMMARY. Cutaneous leishmaniasis with only skin involvement: single to multiple skin ulcers, satellite lesions and nodular lymphangitis.
SUMMARY Leishmaniasis is a disease affecting predominantly people in the developing countries; 350 million people worldwide are at risk and yearly more than 2 million new cases occur. Leishmaniasis is
More informationControl of leishmaniasis
EXECUTIVE BOARD EB118/4 118th Session 11 May 2006 Provisional agenda item 5.1 Control of leishmaniasis Report by the Secretariat BACKGROUND 1. Leishmaniasis is endemic in 88 countries in the world and
More informationApplication for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines:
Application for Inclusion of MILTEFOSINE on WHO Model List of Essential Medicines: Comments re Feb 2011 reviews of the v 2010 application February 23, 2011 1. The application and its review In v 2010,
More informationLeishmaniasis in the WhO european region
Leishmaniasis in the WhO european region This information leaflet contains six sections and is intended for a generic and public health audience: 1.Leishmaniasis is present in europe. What are the risks
More informationHistory of Leishmaniasis (from Wikipedia)
History of Leishmaniasis (from Wikipedia) Descriptions of conspicuous lesions similar to cutaneous leishmaniasis (CL) has been discovered on tablets from King Ashurbanipal from the 7th century BC, some
More informationNew insights on leishmaniasis in immunosuppressive conditions
New insights on leishmaniasis in immunosuppressive conditions Javier Moreno Immunoparasitology Unit WHO Collaborative Center for Leishmaniasis Centro Nacional de Microbiología INSTITUTO DE SALUD CARLOS
More informationAntimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis. Shyam Sundar Banaras Hindu University Varanasi, India
Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis Shyam Sundar Banaras Hindu University Varanasi, India History of the Current Epidemic in India & Antimony Resistance 6 Official
More informationCONTROLE DAS LEISHMANIOSES O QUE FALTA FAZER? Centro de Convenções de Reboças Red Room 17: 00h
CONTROLE DAS LEISHMANIOSES O QUE FALTA FAZER? Centro de Convenções de Reboças 08.04.2014 Red Room 17: 00h Leishmaniasis - a Global Problem Visceral 2012 300 000 cases 20,000 deaths (6.7%) 310 million at
More informationParasitic Protozoa, Helminths, and Arthropod Vectors
PowerPoint Lecture Slides for MICROBIOLOGY ROBERT W. BAUMAN Chapter 23 Parasitic Protozoa, Helminths, and Arthropod Vectors Parasitic Diseases Protozoan and helminthic parasites are emerging as serious
More informationVisceral leishmaniasis: an endemic disease with global impact
Visceral leishmaniasis: an endemic disease with global impact Professor Olivier Lortholary, MD, PhD Department of Infectious and Tropical diseases Hôpital Necker-Enfants Malades Université Paris Descartes
More informationPost Kala-azar Dermal Leishmaniasis (PKDL) In vivo veritas
Post Kala-azar Dermal Leishmaniasis (PKDL) In vivo veritas Mitali Chatterjee Dept. of Pharmacology, Institute of PG Medical Education & Research, Kolkata 26 th August, 2016 1 st February 2017; Health
More informationStudying the Dynamics of Visceral Leishmaniasis Epidemic in India - A System Dynamic Approach for Policy Development
Studying the Dynamics of Visceral Leishmaniasis Epidemic in India - A System Dynamic Approach for Policy Development Hiba Ahmed Supervised by: Pål Davidsen Submitted in Partial Fulfillment Of the Requirement
More informationGENUS: LEISHMANIA. Under the genus Leishmania, there are 2 subgenus: SPECIES PARASITIC IN MEN. Under subgenus Leishmania, there are following species:
GENUS: LEISHMANIA Species parasitic in man: Under the genus Leishmania, there are 2 subgenus: 1. Leishmania 2. Viannia SPECIES PARASITIC IN MEN Under subgenus Leishmania, there are following species: LEISHMANIA
More informationLeishmaniasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course
Leishmaniasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED Acknowledgments LTC James E. Moon, MD Chief, Sleep Trials Branch Walter Reed Army Institute of Research CDR Ramiro
More informationProtozoa from tissues. Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp.
Protozoa from tissues Leishmania spp. Naegleria fowleri Toxoplasma gondii Trichomonas vaginalis Trypanosoma spp. Leishmaniasis Leishmania infantum, Leishmania donovani, in macrophages of man. Female sandflies:
More informationRecommendations for Coping with Leishmaniasis: A Review of Control Strategies. Centro de Convenções de Reboças Red Room 17: 00h
Recommendations for Coping with Leishmaniasis: A Review of Control Strategies Centro de Convenções de Reboças 08.04.2014 Red Room 17: 00h Leishmaniasis - a Global Problem Visceral 2012 300 000 cases 20,000
More informationPrevalence of Cutaneous Leishmaniasis among HIV and Non-HIV Patients attending some Selected Hospitals in Jos Plateau State
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 06 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.706.307
More informationWMLN Case Study. Necrotizing Palate Biopsy Specimen. Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP)
WMLN Case Study Necrotizing Palate Biopsy Specimen Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP) 44 year old male from Honduras Immigrated to US 12 years ago to WI 4 years ago Seen
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007 Hosted by: Australian Small Animal Veterinary Association (ASAVA) Australian Small Animal Veterinary Association (ASAVA)
More informationLeishmaniasis: Current Status of Vaccine Development
CLINICAL MICROBIOLOGY REVIEWS, Apr. 2001, p. 229 243 Vol. 14, No. 2 0893-8512/01/$04.00 0 DOI: 10.1128/CMR.14.2.229 243.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Leishmaniasis:
More informationSeries Editors Samuel J. Black, University of Massachusetts, Amherst, MA, US.A. J. Richard Seed, University of North Carolina, Chapel Hill, NC, US.A.
LEISHMANIA World Class Parasites VOLUME 4 Volumes in the World Class Parasites book series are written for researchers, students and scholars who enjoy reading about excellent research on problems of global
More informationSummary of Cases & Epidemiology Aspects of Leishmaniasis in Thailand
Summary of Cases & Epidemiology Aspects of Leishmaniasis in Thailand Sukmee T. 1, Mungthin M. 2, Apiwathanasorn C. 3, Leelayoova S. 2 1 Department of Microbiology, Phramongkutklao College of Medicine 2
More informationLaboratory investigation of Cutaneous Leishmaniasis in Karachi
Laboratory investigation of Cutaneous Leishmaniasis in Karachi Pages with reference to book, From 248 To 250 G.M. Rajpar, M.A. Khan, A. Hafiz ( Department of Microbiology, Jinnah Postgraduate Medical Centre,
More informationLeishmaniasis: A forgotten disease among neglected people
ISPUB.COM The Internet Journal of Health Volume 11 Number 2 Leishmaniasis: A forgotten disease among neglected people Y Homsi, G Makdisi Citation Y Homsi, G Makdisi. Leishmaniasis: A forgotten disease
More informationBlood Smears Only 07 February Sample Preparation and Quality Control 12B A
NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 07 February 2012 The purpose of the New York State Proficiency Testing Program in the category of Parasitology Blood Smears Only
More information18 : 1. Shyam Sundar, Anup Singh, Arun Shah, Varanasi EPIDEMIOLOGY: DIAGNOSIS OF VL:
18 : 1 Visceral leishmaniasis-current scenario Visceral leishmaniasis (VL) is a systemic disease that is fatal if left untreated and is caused by an obligate intracellular protozoan parasite of genus leishmania.
More informationKala-Azar- Treatment Update
JOURNAL OF ADVANCES IN MEDICINE (JAM) DOI: 10.5958/2319-4324.2016.00002.X REVIEW PAPER Kala-Azar- Treatment Update Anup Singh Associate Professor, Department of Medicine, Institute of Medical Sciences,
More informationDENDRITIC CELLS ACTIVATED BY CpG MOTIFS ARE POTENT INDUCERS OF A TH1 IMMUNE RESPONSE THAT PROTECTS MICE AGAINST LEISHMANIASIS
DENDRITIC CELLS ACTIVATED BY CpG MOTIFS ARE POTENT INDUCERS OF A TH1 IMMUNE RESPONSE THAT PROTECTS MICE AGAINST LEISHMANIASIS Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen
More informationBlack Fever: A Serious Threat on Human Health in West Bengal, India
International Research Journal of Social Sciences ISSN 2319 3565 Black Fever: A Serious Threat on Human Health in West Bengal, India Dawn Anandita Department of Geography, University of Calcutta, Kolkata,
More informationChildren with Visceral Leishmaniasis Presented to Omdurman Emergency Hospital for Children
Original Article Children with Visceral Leishmaniasis Presented to Omdurman Emergency Hospital for Children Elfakey Walyeldinl, Ahmed Muawial, Mohamed Abdurrahman2 and Suwar M 03 Department of Paediatrics
More informationLeishmania and Human Immunodeficiency Virus Coinfection: the First 10 Years
CLINICAL MICROBIOLOGY REVIEWS, Apr. 1997, p. 298 319 Vol. 10, No. 2 0893-8512/97/$04.00 0 Copyright 1997, American Society for Microbiology Leishmania and Human Immunodeficiency Virus Coinfection: the
More informationDrug resistance in Indian visceral leishmaniasis
Tropical Medicine and International Health volume6no11pp849±854november2001 Drug resistance in Indian visceral leishmaniasis Shyam Sundar Kala-azar Medical Research Centre, Banaras Hindu University, Varanasi,
More informationThe status of Visceral Leishmaniasis in India
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2016, 8(8):195-201 Review Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 The status of Visceral Leishmaniasis in India Naveen
More informationA Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples
JCM Accepts, published online ahead of print on 0 June 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationLeishmaniasis. By Joseph Knight, PA-C. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India.
Leishmaniasis By Joseph Knight, PA-C Objectives 1. Identify the two types of leishmaniasis. 2. Explain the differences in the reasons leishmaniasis is spreading in Afghanistan and India. 3. Discuss how
More informationCUTANEOUS LEISHMANIASIS
CUTANEOUS LEISHMANIASIS Why are you neglecting me? A WHO initiative to control Cutaneous Leishmaniasis in selected Old World areas This document has been produced as the result of a WHO Informal Consultative
More informationOral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Tropical Medicine and International Health doi:10.1111/tmi.12015 volume 18 no 1 pp 96 100 january 2013 Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Shyam Sundar 1,
More informationLeishmaniasis: Challenges for Vaccine Development
Leishmaniasis: Challenges for Vaccine Development Steven G. Reed Infectious Disease Research Institute Seattle IDRI Goals: Leishmaniasis To improve existing vaccines for use in therapy and prevention.
More informationKinetoplastids Handout
Kinetoplastids Handout 1 Kinetoplastids widespread group of flagellated protozoa parasitize virtually all animal groups as well as plants and insects 3 distinct kinetoplastid species cause human disease
More information(From the Department of Medicine, the Peiping Union Medical College, Peiping, China)
Published Online: 1 April, 1934 Supp Info: http://doi.org/10.1084/jem.59.4.491 Downloaded from jem.rupress.org on October 9, 2018 VIABLE LEISHMANIA DONOVANI IN NASAL AND ORAL SECRETIONS OF PATIENTS WITH
More informationNeglected Diseases (NDs) Landscape in Brazil and South America
Frontiers in Science on Neglected Diseases 13 th November 2014 Neglected Diseases (NDs) Landscape in Brazil and South America Jeffrey Shaw São Paulo University Biomedical Sciences Institute jeffreyj@usp.br
More informationReview Cutaneous Manifestations of Human and Murine Leishmaniasis
Review Cutaneous Manifestations of Human and Murine Leishmaniasis Breanna M. Scorza 1, Edgar M. Carvalho 2,3 and Mary E. Wilson 1,4,5,6, * 1 Interdisciplinary Graduate Program in Immunology, University
More informationVisceral childhood leishmaniasis in southern Turkey: experience of twenty years
The Turkish Journal of Pediatrics 2009; 51: 1-5 Original Visceral childhood leishmaniasis in southern Turkey: experience of twenty years Oğuz Dursun 1, Seyhan Erişir 2, Akif Yeşilipek 3 Divisions of 1
More informationJarmila Kliescikova, MD. Leishmaniasis
Jarmila Kliescikova, MD Leishmaniasis Leishmania spp. Kinetoplastida More than 20 pathogenic species Disease Cutaneous Transmission: inoculative Amastigotes multiply intracellulary Mucocutaneous Systemic
More informationFlagellates. Dr. Anuluck Junkum PARA
Flagellates Dr. Anuluck Junkum PARA 317242 Objective Can describe the morphology, life cycle, pathology, diagnosis and prevention of pathogenic flagellates Classification of Protozoa Based on locomotive
More informationPolicy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis
REGIONAL COMMITTEE Provisional Agenda item 8.3 Sixty-eighth Session SEA/RC68/12 Dili, Timor-Leste 7 11 September 2015 21 July 2015 Policy and technical topics: Selected neglected tropical diseases targeted
More informationCutaneous Leishmaniasis in an Immigrant Saudi Worker: A Case Report
J HEALTH POPUL NUTR 2014 Jun;32(2):372-376 ISSN 1606-0997 $ 5.00+0.20 INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH, BANGLADESH CASE STUDY Cutaneous Leishmaniasis in an Immigrant Saudi Worker: A
More informationCHAPTER-1 LEISHMANIASIS: INTRODUCTION
CHAPTER-1 LEISHMANIASIS: INTRODUCTION 1.1 An Overview Leishmania spp. are digenetic obligatory intracellular parasitic protozoans that survive in hostile environments the midgut of the insect vector and
More informationReport of the. Fifth Consultative Meeting on Leishmania/HIV Coinfection. Addis Ababa, Ethiopia, March 2007
Report of the Fifth Consultative Meeting on Leishmania/HIV Coinfection Addis Ababa, Ethiopia, 20 22 March 2007 WHO/CDS/NTD/IDM/2007.5 Report of the Fifth Consultative Meeting on Leishmania/HIV Coinfection
More informationCutaneous leishmaniasis in an overseas Filipino worker who responded favorably to oral itraconazole
CSE REPORT Cutaneous leishmaniasis in an overseas Filipino worker who responded favorably to oral itraconazole udi, MD 1, ilza ellamy R. Limcangco, MD, FPDS 2, Johannes F, Dayrit, MD, FPDS 2,3 Introduction:
More informationVisceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control
Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control Anette Stauch 1., Ram Rup Sarkar 2., Albert Picado 3, Bart Ostyn 3, Shyam Sundar 4, Suman Rijal 5, Marleen Boelaert
More informationRapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease(review)
Cochrane Database of Systematic Reviews Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease(review) BoelaertM,VerdonckK,MentenJ,SunyotoT,vanGriensvenJ,ChappuisF,RijalS
More informationSafety and immunogenicity of a new Leishmania vaccine candidate ChAd63-KH
Safety and immunogenicity of a new Leishmania vaccine candidate ChAd63-KH Study Acronym: LEISH2a ClinicalTrials.gov ID: NCT02894008 25th LEAP meeting, 3-5 Sep 2018 Entebbe, Uganda Ahmed M Musa MBBS, DTM
More informationPost Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels
Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels A M EL Hassan Institute of Endemic Diseases University of Khartoum Introduction PKDL is a VL related
More informationSingle-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study
MAJOR ARTICLE Single-Dose Liposomal Amphotericin B in the Treatment of Visceral Leishmaniasis in India: A Multicenter Study S. Sundar, 1 T. K. Jha, 2 C. P. Thakur, 3 M. Mishra, 4 V. P. Singh, 1 and R.
More informationThe Struggle with Infectious Disease. Lecture 5
The Struggle with Infectious Disease Lecture 5 Tropical Diseases Life and infectious disease began in the rift valley/rain forest of Eastern Africa Peoples migrated North to temperate regions Tropical
More informationاعداد رغداحمد رغد جمال الدين
اعداد رغداحمد رغد جمال الدين Trypanosoma Causes Trypanosomiasis West African Trypanosomiasis T.brucei gambiense Sleeping sickness East African Trypanosomiasis T.brucei rhodesiense American Trypanosomiasis
More informationLeishmania/HIV co-infections in the second decade
Review Article Indian J Med Res 123, March 2006, pp 357-388 Leishmania/HIV co-infections in the second decade Israel Cruz, Javier Nieto, Javier Moreno, Carmen Cañavate, Philippe Desjeux* & Jorge Alvar**
More informationDisease Transmission Methods
Disease Transmission Methods In epidemiology, transmission simply means any method by which an infectious agent is spread from one host to another. Knowing the type of pathogen often, but not always, identifies
More informationSurveillance for Visceral Leishmaniasis in Iraq
Field Epidemiology Training Programs Case Studies in Applied Epidemiology No. 113-D12 Surveillance for Visceral Leishmaniasis in Iraq Student's Guide Learning Objectives After completing this case study,
More informationVisceral leishmaniasis: what are the needs for diagnosis, treatment and control?
EVALUATING DIAGNOSTICS Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? François Chappuis*, Shyam Sundar, Asrat Hailu, Hashim Ghalib, Suman Rijal #, Rosanna W. Peeling,
More informationby author Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018
Drug Therapy in African Visceral Leishmaniasis 28th ECCMID Conference, Madrid, Spain 21 April 2018 Dr. Monique Wasunna, Director, DNDi Africa Regional Office Presentation Outline 1 2 4 5 Introduction leishmaniasis
More informationRepellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd
The Jojoo Mosquito Repellent Soap Africa s innovative solution to Malaria prevention Sapphire Trading Company Ltd P.O.Box: 45938-00100 Nairobi, Kenya. Tel: +254 735 397 267 +254 733 540 868 +254 700 550
More informationReview of Literature: Leishmaniasis
Review of Literature: Leishmaniasis Leishmaniasis Parasitic diseases were always a heavy burden for humanity. Protozoan parasites are responsible for several important diseases that threaten the lives
More informationLeishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 )
Leishmaniasis caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) Cutaneous Leishmaniasis Mucocutaneous Leishmaniasis Visceral Leishmaniasis About 12 million people are currently
More informationCutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics
Clinical dermatology Review article CED Clinical and Experimental Dermatology Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics M. Ameen Royal Free Hospital, Royal
More informationImpavido. (miltefosine) New Product Slideshow
Impavido (miltefosine) New Product Slideshow Introduction Brand name: Impavido Generic name: Miltefosine Pharmacological class: Antileishmanial agent Strength and Formulation: 50mg; hard gel capsules Manufacturer:
More informationLeishmaniasis. caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) 皮膚型黏膜型內臟型. Cutaneous Leishmaniasis
Leishmaniasis caused by Leishmania spp. 利什曼原蟲 transmitted by Phlebotomine flies (Sandflies 白蛉 ) 皮膚型黏膜型內臟型 Cutaneous Leishmaniasis Mucocutaneous Leishmaniasis Visceral Leishmaniasis About 12 million people
More informationEvaluation of rk28 antigen for serodiagnosis of visceral Leishmaniasis in India
ORIGINAL ARTICLE TROPICAL AND PARASITIC DISEASES Evaluation of rk8 antigen for serodiagnosis of visceral Leishmaniasis in India M. Vaish, A. Bhatia, S. G. Reed, J. Chakravarty and S. Sundar ) Department
More informationSEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE
SEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE 1 Ibrahim A. Al Zubaidy, 2 Hasanain A. Al Saeedi & 3 Ban S.Al-Nasery 1,3 Zoonotic diseases researches unit/ College of Veterinary Medicine/
More informationKINETOPLASTIDS. Kinetoplast. Nucleus
KINETOPLASTIDS Kinetoplast Nucleus widespread parasites animals (fish humans) insects plants monophyletic group related to euglenoids unifying feature = kinetoplast Giemsa staining structure KINETOPLAST
More informationCHANGING CLINICAL PROFILE OF KALA-AZAR IN CHILDREN PATIENT: A HOSPITAL BASED STUDY
International Journal of Innovation Sciences and Research Vol.4, No, 7, pp.340-346, July- 2015 RESEARCH ARTICLE Available online at http://www.ijisr.com CHANGING CLINICAL PROFILE OF KALA-AZAR IN CHILDREN
More informationSEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE
SEROLOGICAL STUDY OF VISCERAL LEISHMANIASIS IN WASSIT GOVERNOTATE 1 Ibrahim A. Al Zubaidy, 2 Hasanain A. Al Saeedi & Ban S.Al-Nasiry 3 1,3 Zoonotic diseases researches unit/ College of Veterinary Medicine/
More informationLeishmaniasis. Leishmaniasis.
Page 1 of 11 Leishmaniasis From Wikipedia, the free encyclopedia Leishmaniasis, also spelled leishmaniosis, is a disease caused by protozoan parasites of the genus Leishmania and spread by the bite of
More informationNanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul)
Faculty of Pharmacy of the University of Lisbon Nanomedicine & Drug Delivery Systems Group Research Institute for Medicines and Pharmaceutical Sciences (imed.ul) Leishmania in southern Europe. (Duiardin,
More informationMalaria parasites Malaria parasites are micro-organisms that belong to the genus Plasmodium. There are more than 100 species of Plasmodium, which can infect many animal species such as reptiles, birds,
More informationInvest in the future, defeat malaria
Invest in the future, defeat malaria Malaria is caused by parasites from the genus Plasmodium, which are spread to people by infected mosquitoes. There are five species of Plasmodium that can infect humans.
More information